What the company does
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocytopenia (ITP), thrombocytopenia, and patients with severe aplastic anemia (SAA); Tafinlar+Mekinist, an oral combination therapy to treat patients with certain types of cancers; and Jakavi for the treatment of …
What the weekly tape is saying
NVS closed the latest completed week at 57,275 ARS. The 4-week return is 4.1% and the 12-week return is 6.8%. Trend Signal is active, Market Dynamics is -0.61. Setup signature: Balanced read with a 47/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 55,250 ARS
- Vs Trend Line
- 3.7%
- Fair Value
- 35,794 ARS
- Vs Fair Value
- 60.0%
- 52W High
- 63,199 ARS
- 52W Low
- 33,649 ARS
- Drawdown
- -9.4%
- Range Position
- 80.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 63 weeks
- 52W Active Weeks
- 52
- 52W Active Breadth
- 100.0%
- Sector Scope
- AR Healthcare
- Sector Rank
- 4 of 20
- Sector Percentile
- 84.2%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AR Healthcare
- Tracked Peers
- 20
- 4W Rank
- 13 of 20
- Avg 1W
- -0.5%
- Avg 4W
- 5.2%
- Trend Breadth
- 25.0%
- Positive MD
- 20.0%
AR Drug Manufacturers - General
- Tracked Peers
- 13
- 4W Rank
- 8 of 13
- Avg 1W
- -0.6%
- Avg 4W
- 4.9%
- Trend Breadth
- 38.5%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.61
- 4W MD Change
- 22.8%
- Relative Strength
- -13.18
- 4W RS Change
- -403.9%
- Expectation
- Positive
- Probability
- 57.97%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 260
- 13W Average
- 1.8K
- 52W Average
- 1.4K
- Vs 13W
- 0.1x
- Vs 52W
- 0.2x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 2.7%
- 52W Volatility
- 3.6%
- Upside Weeks
- 32
- Downside Weeks
- 20
- Downside Breadth
- 38.5%
- Avg Gain / Loss
- 3.2% / -2.6%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- BUE
- Country
- AR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- ARS
- Market Cap
- 51900.1B
Opportunity signals
- Trend Signal is active with a 63-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Market Dynamics is negative, which weakens the current setup.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 57,275 ARS | 1.7% | 55,250 ARS | 35,794 ARS | -0.61 | -13.18 | 260 | On |
| 5 Jun 2026 | 56,325 ARS | 0.9% | 54,973 ARS | 35,508 ARS | -0.56 | -7.17 | 1.9K | On |
| 29 May 2026 | 55,850 ARS | -1.1% | 54,651 ARS | 35,226 ARS | -0.60 | -10.17 | 1.6K | On |
| 22 May 2026 | 56,475 ARS | 2.6% | 54,341 ARS | 34,945 ARS | -0.64 | 1.29 | 7.5K | On |
| 15 May 2026 | 55,025 ARS | 1.1% | 54,159 ARS | 34,660 ARS | -0.79 | 4.34 | 5.0K | On |
| 8 May 2026 | 54,400 ARS | -2.0% | 54,025 ARS | 34,385 ARS | -0.85 | 1.53 | 1.1K | On |
| 1 May 2026 | 55,500 ARS | 2.1% | 53,834 ARS | 34,112 ARS | -0.83 | 1.73 | 443 | On |
| 24 Apr 2026 | 54,375 ARS | -2.2% | 53,668 ARS | 33,832 ARS | -0.72 | -0.25 | 1.3K | On |
| 17 Apr 2026 | 55,600 ARS | -1.9% | 53,372 ARS | 33,556 ARS | -0.76 | 0.69 | 1.8K | On |
| 10 Apr 2026 | 56,700 ARS | -1.8% | 53,120 ARS | 33,272 ARS | -0.82 | -0.64 | 550 | On |
| 3 Apr 2026 | 57,750 ARS | 5.4% | 52,764 ARS | 32,970 ARS | -0.63 | 1.47 | 1.3K | On |
| 27 Mar 2026 | 54,800 ARS | 2.1% | 52,335 ARS | 32,661 ARS | -0.24 | 3.63 | 167 | On |
| 20 Mar 2026 | 53,650 ARS | -5.1% | 51,932 ARS | 32,368 ARS | 0.47 | 4.45 | 306 | On |
| 13 Mar 2026 | 56,525 ARS | -4.6% | 51,557 ARS | 32,075 ARS | 1.10 | 14.05 | 623 | On |